Resource Library
Showing 1 to 10 of 212 results
Image
Beyond active surveillance (the ‘watch and wait approach’) there are several CLL treatments to consider. Each treatment has different features and side effects. It is important to be comfortable with the CLL treatment you choose.
Image
Lymphoplasmacytic lymphoma (LPL) and its related condition, Waldenström macroglobulinemia (WM), are slow-growing subtypes of non-Hodgkin lymphoma.
Image
Learn about PTCL, how it is diagnosed, an overview of treatments and what happens next
Image
Advances in research on mantle cell lymphoma (MCL) are resulting in more options to treat the disease and improve the quality of life for people affected by him. Treatment for MCL, which is a type of non-Hodgkin lymphoma, can include chemotherapy, targeted therapy, stem cell transplant, radiation, and immunotherapy.
Image
Learn about developments in understanding and treating myelodysplastic syndromes; Why people develop myelodysplastic syndromes; the evolving role genetic testing is playing in understanding this and novel therapies.
Image
In this webcast, Dr. Donna Reece, hematologist at Princess Margaret Cancer Centre/University of Toronto, talk about the current and new treatments for myeloma. She is also sharing what is being done to help improve the quality of life myeloma patients.
Image
Myeloma, which is a cancer of the plasma cells, is the second most common form of blood cancer in Canada. It most often appears in men, those over the age of 60, and more often in people of African ancestry
Image
Both cancer and your treatment can cause side effects. A common side effect is damage to the cells that line the inside of your mouth and throat.
Image
This worksheet provides a pain scale log for you to keep track of pain level, time and date when you're in treatment for a blood cancer.
Image
Dr. Florian Kuchenbauer explains the basics of AML diagnosis, treatment, side effects, and research.